| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |